WATERS CORPORATION
NYSE: WAT (Waters Corporation)
Kemas kini terakhir: 5 jam lalu289.16
-11.40 (-3.79%)
| Penutupan Terdahulu | 300.56 |
| Buka | 300.31 |
| Jumlah Dagangan | 644,394 |
| Purata Dagangan (3B) | 1,049,677 |
| Modal Pasaran | 28,367,136,768 |
| Harga / Pendapatan (P/E TTM) | 26.87 |
| Harga / Pendapatan (P/E Ke hadapan) | 20.79 |
| Harga / Jualan (P/S) | 5.64 |
| Harga / Buku (P/B) | 11.45 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 May 2026 |
| Margin Keuntungan | 22.02% |
| Margin Operasi (TTM) | 22.93% |
| EPS Cair (TTM) | 11.01 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 3.90% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 18.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 78.58% |
| Nisbah Semasa (MRQ) | 1.81 |
| Aliran Tunai Operasi (OCF TTM) | 758.81 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 588.83 M |
| Pulangan Atas Aset (ROA TTM) | 11.61% |
| Pulangan Atas Ekuiti (ROE TTM) | 40.82% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Waters Corporation | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | 3.0 |
| Volatiliti Harga | 3.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -2.0 |
| Purata | 2.20 |
|
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 0.16% |
| % Dimiliki oleh Institusi | 98.23% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 460.00 (HSBC, 59.08%) | Beli |
| Median | 370.00 (27.96%) | |
| Rendah | 350.00 (Morgan Stanley, 21.04%) | Pegang |
| 350.00 (B of A Securities, 21.04%) | Pegang | |
| Purata | 389.29 (34.63%) | |
| Jumlah | 3 Beli, 4 Pegang | |
| Harga Purata @ Panggilan | 336.76 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Morgan Stanley | 23 Feb 2026 | 350.00 (21.04%) | Pegang | 327.78 |
| Barclays | 11 Feb 2026 | 400.00 (38.33%) | Beli | 329.20 |
| Wells Fargo | 11 Feb 2026 | 355.00 (22.77%) | Pegang | 329.20 |
| B of A Securities | 10 Feb 2026 | 350.00 (21.04%) | Pegang | 327.02 |
| Guggenheim | 10 Feb 2026 | 440.00 (52.16%) | Beli | 327.02 |
| UBS | 10 Feb 2026 | 370.00 (27.96%) | Pegang | 327.02 |
| HSBC | 27 Jan 2026 | 460.00 (59.08%) | Beli | 390.09 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| JIANG WEI | 290.02 | - | 500 | 145,010 |
| Jumlah Keseluruhan Kuantiti Bersih | 500 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 145,010 | |||
| Purata Pembelian Keseluruhan ($) | 290.02 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| JIANG WEI | Pengarah | 16 Mar 2026 | Beli (+) | 500 | 290.02 | 145,010 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 27 Jan 2026 | Pengumuman | Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business |
| 27 Jan 2026 | Pengumuman | BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business |
| 20 Jan 2026 | Pengumuman | Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |